PSIL Holdings — AdvisorShares Psychedelics ETF
All 32 reported holdings of AdvisorShares Psychedelics ETF (PSIL) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Definium Therapeutics, Inc. | 12.85% | $5.71M |
| Compass Pathways PLC | 11.45% | $5.09M |
| Ataibeckley, Inc. | 10.47% | $4.65M |
| Relmada Therapeutics, Inc. | 6.84% | $3.04M |
| Nrx Pharmaceuticals, Inc. | 6.07% | $2.70M |
| Neurocrine Biosciences, Inc. | 4.38% | $1.95M |
| Cybin, Inc. | 4.35% | $1.93M |
| Gh Research PLC | 4.31% | $1.92M |
| Alkermes PLC | 4.30% | $1.91M |
| Alto Neuroscience, Inc. | 4.20% | $1.87M |
| Abbvie, Inc. | 4.14% | $1.84M |
| Blackrock Treasury Trust | 3.97% | $1.76M |
| Bright Minds Biosciences, Inc. | 3.84% | $1.70M |
| Johnson & Johnson | 3.61% | $1.60M |
| Drey Inst Pref Gov Mm-M | 3.10% | $1.38M |
| Supernus Pharmaceuticals, Inc. | 2.89% | $1.28M |
| Neuphoria Therapeutics, Inc. | 2.49% | $1.11M |
| Neuronetics, Inc. | 2.17% | $965.63K |
| Quantum Biopharma Ltd. | 1.66% | $736.90K |
| Optimi Health Corp. | 1.18% | $523.22K |
| Pasithea Therapeutics Corp. | 1.09% | $483.21K |
| Silo Pharma, Inc. | 1.06% | $469.36K |
| Psyence Biomedical Ltd. | 0.84% | $373.88K |
| Incannex Healthcare, Inc. | 0.52% | $228.86K |
| Numinus Wellness, Inc. | 0.47% | $209.08K |
| Igc Pharma, Inc. | 0.42% | $184.55K |
| Vistagen Therapeutics, Inc. | 0.22% | $99.13K |
| Enveric Biosciences, Inc. | 0.11% | $48.88K |
| Clearmind Medicine, Inc. | 0.01% | $2.57K |
| Unbuzzd Wellness, Inc. | 0.00% | $0 |
| Sage Therapeutics, Inc. | 0.00% | $0 |
| Quantum Biopharma | 0.00% | $0 |
PSIL overview: performance, fees, allocation and SEC filings